Listen to a blog summary of a recent research paper published by Oncotarget, entitled, "Immunotherapy Response Predicted by Machine Learning & Gut Microbiomes."
__________________________________________
Immunotherapy has become a powerful breakthrough in cancer treatment, however, 50% of patients do not respond to immunotherapy. What internal or external features inhibit or confer patient or tumor response to immune system-harnessing therapeutics? These patient/tumor features that impact responsiveness to immunotherapy have yet to be fully elucidated.
“Increasing evidence has emerged that gut microbial communities help shape the host immune system [9–11].”
Full blog - https://www.oncotarget.org/2022/09/01/immunotherapy-response-predicted-by-machine-learning-gut-microbiomes/
DOI - https://doi.org/10.18632/oncotarget.28252
Correspondence to - Heidi H. Kong - konghe@mail.nih.gov
Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632/oncotarget.28252
Keywords - gut microbiome; immunotherapy; 16S rRNA; machine learning; metagenomics
About Oncotarget
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed.
To learn more about Oncotarget, please visit www.oncotarget.com and connect with us:
SoundCloud - @oncotarget
Facebook - www.facebook.com/Oncotarget/
Twitter - twitter.com/oncotarget
Instagram - www.instagram.com/oncotargetjrnl/
YouTube - www.youtube.com/OncotargetYouTube
LinkedIn - www.linkedin.com/company/oncotarget
Pinterest - www.pinterest.com/oncotarget/
Reddit - www.reddit.com/user/Oncotarget/
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957
